Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID | D0TV9X | ||||
| Former ID | DNC010414 | ||||
| Drug Name | Propan-2-one O-4-(octyloxy)phenylcarbamoyl oxime | ||||
| Drug Type | Small molecular drug | ||||
| Indication | Discovery agent | Investigative | [530604] | ||
| Formula | C18H28N2O3 | ||||
| Canonical SMILES | CCCCCCCCOC1=CC=C(C=C1)NC(=O)ON=C(C)C | ||||
| InChI | 1S/C18H28N2O3/c1-4-5-6-7-8-9-14-22-17-12-10-16(11-13-17)19-18(21)23-20-15(2)3/h10-13H,4-9,14H2,1-3H3,(H,19,21) | ||||
| InChIKey | CZUCVARHDLBFBC-UHFFFAOYSA-N | ||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530604] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.
